Park Medi World Limited Q3 FY26 earnings call summary

Earnings call of 29 Jan 2026, summarised by AI from the filing.

Park Medi World Q3 FY26 revenue ₹4,100 million, EBITDA margin 24%, PAT ₹528 million; guides 26-27% EBITDA margin long term.

Key takeaways

1. Capacity expansion Adding 2,010 beds by March 2028 with ₹700 cr capex.

Original filing on BSE

Park Medi World Limited Q1 FY27 results

As filed: Revenue ₹476 cr, EBITDA ₹126 cr, PAT ₹88.6 cr, EBITDA margin 26.5%.

Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹476 cr). Scored once a year-earlier consolidated quarter exists.

Earlier results and the share price after them

• Q4 FY26: Revenue ₹460 cr, EBITDA ₹127 cr, PAT ₹76.8 cr, EBITDA margin 27.7%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹460 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +5.2% in 30 days (Nifty 500: −3.0%).
• Q3 FY26: Revenue ₹410 cr, EBITDA ₹99.4 cr, PAT ₹52.9 cr, EBITDA margin 24.3%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹410 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +29.5% in 30 days (Nifty 500: +1.5%).

Past price moves after results do not indicate future moves. Not a recommendation.

Park Medi World Limited earnings call, investor presentation and press release summaries

• Q1 FY27: Earnings call (4 Aug 2026), Results deck (3 Aug 2026), Results press release (3 Aug 2026)
• Q4 FY26: Earnings call (13 May 2026), Results deck (12 May 2026), Results press release (12 May 2026)
• Q3 FY26: Earnings call (29 Jan 2026), Results deck (28 Jan 2026), Results deck (28 Jan 2026)